Skip to main content
Clinical Trials/JPRN-UMIN000020203
JPRN-UMIN000020203
Completed
未知

Study of a heart failure treatment using a combination drug consisting of reduced coenzyme Q10, astaxanthin, citrulline, and zinc - Study of a heart failure treatment using a combination drug consisting of reduced coenzyme Q10, astaxanthin, citrulline, and zinc

Tokorozawa Heart Center, Medical Corporation Ouyuukai0 sites50 target enrollmentDecember 15, 2015
Conditionsheart failure

Overview

Phase
未知
Intervention
Not specified
Conditions
heart failure
Sponsor
Tokorozawa Heart Center, Medical Corporation Ouyuukai
Enrollment
50
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 15, 2015
End Date
March 31, 2017
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Tokorozawa Heart Center, Medical Corporation Ouyuukai

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1\)Patients who meet the following criteria are excluded: those who have not completely recovered from a malignancy; with severe infection; suspected of having a pulmonary disease (including COPD) on a chest radiogram; who are on dialysis; and others who are found unacceptable at the discretion of the physician (2\)Patients who have taken drugs or supplements including coenzyme Q10, astaxanthin, and citrulline within the last 2 months

Outcomes

Primary Outcomes

Not specified

Similar Trials